Professor Ali Altimimi
@au.edu.iq
Medical College , Department of Anatomy & Pathology ,Ashur university, Iraq.
Ashur University
Professor Ali Hassan Altimimi graduated from the Iraqi College of Medicine1976. He moved from Iraq to complete his postgraduate studies in Europe and then in the United States of America. He studied and trained at the best international university & medical institute including the Royal Victoria College in Britain and the Universities of Bonn and Marburg (Germany), Innsbruck (Austria) &Zurich (Switzerland). He also underwent trainings at University Hospitals in London ,Hamburg and California, Kiel. Professor of pathophysiology and anatomy and a scientific 1984-1987.
Lectured at the University of California, Hanover, and Jena in Germany..He worked in European and American Cardiovascular Hospitals and Massachusetts General Hospitals in Boston/USA. Professor Ali AlTimimi obtained his 2nd Ph.D. at the University of Bonn and holds a postgraduate doctorate in medicine from University College Royal Victoria Manchester, England, and Frankfurt (Germany)
EDUCATION
PhD degree in Oral Histopathology& Hematopathology, December 1984 / Royal College Medicine /Queen Victoria University Manchester / Royal College Medicine / England
Master's degree in medical science / MSC microanatomy, and anatomical Physiology 1982, Royal College of Medicine / Queen Victoria University Manchester / Manchester / England
MBChB degree, Medical Collage, Iraq 1976 / MEDICINE, SURGERY AND MEDICAL SCIENCE
RESEARCH, TEACHING, or OTHER INTERESTS
Pathology and Forensic Medicine, Medicine, Anatomy, Physiology (medical)
Scopus Publications
Scholar Citations
Scholar h-index
Scholar i10-index
Scopus Publications
Ali Hassan AI-Timimi and Ahmed Obaid Hossain
Diva Enterprises Private Limited
J Dolan, A H Al-Timimi, S M Richards, J B Jeffs, G C Mason, D B Smith, and P S Hasleton
BMJ
Probable progesterone production was identified by an immunoperoxidase assay in a case of an ovarian sex cord tumour with annular tubules. The tumour was associated with a serous cystadenofibroma in the opposite ovary and with adenoma malignum (adenocarcinoma) of the cervix.
A Al-Timimi, C H Buckley, and H Fox
Springer Science and Business Media LLC
A. Al-Timimi, C. H. Buckley, and H Fox
Ovid Technologies (Wolters Kluwer Health)
An immunocytochemical double horseradish peroxidase-anti-horseradish peroxidase (PAP) technique has been developed for localising estrogen, testosterone, and progesterone binding sites in normal ovaries and in epithelial ovarian neoplasms. Estrogen binding sites were present in 45% of normal ovaries, in 45% of benign epithelial neoplasms, and in 58.5% of ovarian adenocarcinomas. The equivalent figures for progesterone binding sites were 49%, 65%, and 45.2%, whilst those for testosterone binding sites were 43%, 40%, and 60.5%. Steroid binding was related neither to the grade of malignancy in epithelial neoplasms nor to the presence of metastases in cases of ovarian adenocarcinomas. The simultaneous presence of both estrogen and progesterone binding sites or of both estrogen and testosterone binding sites in ovarian adenocarcinomas was, however, associated with good differentiation. Evidence is presented to suggest that the binding sites demonstrated were specific, and it is suggested that the immunohistochemical demonstration of sex steroid hormone binding capacities in ovarian adenocarcinomas may be of value as a predictive marker for response to hormonal therapy.